atropine has been researched along with pyranoprofen in 3 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (pyranoprofen) | Trials (pyranoprofen) | Recent Studies (post-2010) (pyranoprofen) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 128 | 16 | 55 |
| Protein | Taxonomy | atropine (IC50) | pyranoprofen (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 9.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Kawata, M; Matsuura, Y; Sagara, K; Shibata, M; Yamada, I | 1 |
3 other study(ies) available for atropine and pyranoprofen
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Atropine; Benzopyrans; Biological Availability; Chemistry, Pharmaceutical; Cholinergic Antagonists; Delayed-Action Preparations; Digestive System; Digestive System Physiological Phenomena; Dogs; Half-Life; Intestinal Absorption; Male; Pentagastrin; Pharmacokinetics; Propionates; Solubility | 1996 |